FDA Clearance Tracker · P000058-S096
Infuse Bone Graft
Last checked: Nov 20, 2026Latest source record: Feb 13, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 13, 2026
Approved
Time to decision
178 days
Received Aug 19, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P000058-S096
- Device name
- Infuse Bone Graft
- Applicant
- Medtronic Sofamor Danek USA, Inc.
- Applicant location
- Memphis, TN
- Received
- Aug 19, 2025
- Decided
- Feb 13, 2026
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P000058
Device type
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
Infuse Bone Graft with an FDA cleared intervertebral body fusion device and metallic screw-and-rod system is indicated for use in a transforaminal lumbar interbody fusion (TLIF) surgical approach at one or two adjacent levels from L2-S1 in the treatment of symptomatic degenerative disc disease (DDD) confirmed by patient history and radiographic studies and having at least six months of nonoperative treatment attempted prior to treatment with Infuse Bone Graft.
Source documents
Other decisions for Medtronic Sofamor Danek USA, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262572 · Decided Oct 29, 2026 · 94 days after receipt
Device type: Intervertebral Fusion Device With Bone Graft, Lumbar (MAX) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.